HB1292 Expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.
Expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.
Impact Score — How Does This Bill Affect You?
Overall Impact Score
Mixed
Scale: 1 (harmful) to 10 (beneficial)
Your Wallet
Experimental therapies are often expensive and not covered by insurance.
Your Community
Could provide hope for patients with severe illness, but unproven treatments carry risks.
Your Freedom
Expands patient autonomy to try experimental treatments for severe illness, a significant personal freedom.
Status
Refer for Interim Study: Motion Adopted Voice Vote 03/05/2026 House Journal 6 P. 24
Sponsor
Erica Layon (R)
The Short Version
Would have expanded NH's Right to Try Act to include severe (not just terminal) illness and allow regenerative stem cell therapies. Sent to interim study for further review.
Who's Behind This Bill?
Who Benefits
- ▲ Patients with severe illness seeking experimental treatments
- ▲ Regenerative medicine providers
Who Pays the Price
- ▼ Patients who may be harmed by unproven treatments
- ▼ Healthcare system credibility
Bill statuses as of May 2026. Check LegiScan or NH General Court for the latest.
This bill was auto-scored using AI analysis of the bill text and legislative data. Scores may be refined as we review more bills.